Le Lézard
Classified in: Science and technology
Subjects: Conference, Webcast, Advisory

Rockwell Automation to Present at Oppenheimer's 19th Annual Industrial Growth Conference


Rockwell Automation, Inc. (NYSE: ROK) Senior Vice President, Lifecycle Services, Matt Fordenwalt, and Vice President, Investor Relations and Market Strategy, Aijana Zellner, will present virtually at Oppenheimer's 19th Annual Industrial Growth Conference on Wednesday, May 8, 2024.

The fireside chat will be webcast beginning at approximately 12:45 p.m. EDT and will be available on the Rockwell Automation Investor Relations website at www.rockwellautomation.com/en-us/investors.html.

About Rockwell Automation

Rockwell Automation, Inc. (NYSE: ROK), is a global leader in industrial automation and digital transformation. We connect the imaginations of people with the potential of technology to expand what is humanly possible, making the world more productive and more sustainable. Headquartered in Milwaukee, Wisconsin, Rockwell Automation employs approximately 29,000 problem solvers dedicated to our customers in more than 100 countries. To learn more about how we are bringing the Connected Enterprise to life across industrial enterprises, visit www.rockwellautomation.com.


These press releases may also interest you

at 07:22
Tiger Brokers (HK) ("Tiger Brokers (HK)" or "Tiger...

at 07:17
NAPCO Security Technologies, Inc. , one of the leading manufacturers and designers of high-tech...

at 07:10
bluebird bio, Inc. announced today that it will host a conference call to discuss first quarter 2024 results and business updates on May 9, at 8:00 a.m. ET. To participate in the conference call, please dial +1 (800) 715-9871 (U.S. and Canada) and...

at 07:05
RSA CONFERENCE ? As a new crop of AI-related threats emerges from the rapid adoption of generative AI (GenAI) tools within application development, Checkmarx, the industry leader in cloud-native application security for the enterprise, has forged a...

at 07:05
Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced it received a Notice of Allowance from the European Patent Office for its...

at 07:05
Stoke Therapeutics, Inc. , a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today reported financial results for the first quarter of 2024 and...



News published on and distributed by: